Redmile Group, LLC

Insider Reports History

Location
San Francisco, CA
Signature
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Redmile Group, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
MedAvail Holdings, Inc. Director, 10%+ Owner Common Stock 34,604,516 $197,145,388 $5.70 01 Jul 2022 Indirect
MedAvail Holdings, Inc. Director, 10%+ Owner Common Stock 19,097,796 $108,802,054 $5.70 01 Jul 2022 Direct
ADC Therapeutics SA 10%+ Owner Common Shares, par value CHF 0.08 per share 15,666,731 $59,690,245 $3.81 11 Dec 2024 Indirect
ADC Therapeutics SA 10%+ Owner Common Shares, par value CHF 0.08 per share 13,145,712 $50,085,163 $3.81 11 Dec 2024 Direct
Absci Corp Director Common Stock 8,262,136 $41,142,959 $4.98 12 Jun 2024 Indirect
RayzeBio, Inc. 10%+ Owner Common Stock 1,857,706 $33,438,708 $18.00 19 Sep 2023 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Common Stock 1,954,420 $31,251,176 $15.99 02 Nov 2021 Indirect
Zymeworks Inc. 10%+ Owner Common Stock, par value $0.00001 per share 6,075,918 $30,584,956 $5.03 13 Oct 2022 Indirect
FATE THERAPEUTICS INC Director, 10%+ Owner Class A Convertible Preferred Stock 2,755,086 $23,142,722 $8.40 20 Dec 2024 Indirect
FATE THERAPEUTICS INC Director, 10%+ Owner Common Stock 12,884,277 $21,645,585 $1.68 20 Dec 2024 Indirect
Verve Therapeutics, Inc. 10%+ Owner Common Stock 1,936,530 $19,365,300 $10.00 21 Jun 2021 Indirect
ADC Therapeutics SA 10%+ Owner Pre-Funded Warrants 3,846,153 $14,999,996 $3.90 27 Oct 2025 Direct
ADC Therapeutics SA 10%+ Owner Pre-Funded Warrants 3,846,153 $14,999,996 $3.90 27 Oct 2025 Indirect
Adagio Therapeutics, Inc. 10%+ Owner Common Stock 3,390,960 $13,394,292 $3.95 10 Aug 2021 Indirect
MedAvail Holdings, Inc. Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 38,916,562 $12,500,000 $0.3212 09 Mar 2023 Direct
MedAvail Holdings, Inc. Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 38,916,562 $12,500,000 $0.3212 09 Mar 2023 Indirect
Shattuck Labs, Inc. Director, 10%+ Owner Common Stock, par value $0.0001 per share 5,539,724 $6,924,655 $1.25 04 Dec 2024 Indirect
IGM Biosciences, Inc. Director, 10%+ Owner Common Stock 0 $3,528,163 $1.19 14 Aug 2025 Indirect
Atara Biotherapeutics, Inc. Director Common Stock, par value $0.0001 per share 441,701 $3,356,927 $7.60 16 May 2025 Indirect
FATE THERAPEUTICS INC Director, 10%+ Owner Cash-settled Swaps 502,769 $844,652 $1.68 20 Dec 2024 Indirect
FATE THERAPEUTICS INC Director, 10%+ Owner Stock Option (Right to Buy) 55,000 $109,200 $2.73 29 May 2025 Indirect
Augmedix, Inc. Director, 10%+ Owner Common Stock 0 $0 $2.35 02 Oct 2024 Direct
Augmedix, Inc. Director, 10%+ Owner Common Stock 0 $0 $2.35 02 Oct 2024 Indirect
Augmedix, Inc. Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 0 $0 $1.60 02 Oct 2024 Direct
Augmedix, Inc. Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 0 $0 $1.60 02 Oct 2024 Indirect
Science 37 Holdings, Inc. Former 10% Owner and Director Common Stock 0 $0 $5.75 12 Mar 2024 Indirect
MedAvail Holdings, Inc. Director, 10%+ Owner Series A Warrants to Purchase Common Stock 38,916,562 16 Jun 2023 Direct
MedAvail Holdings, Inc. Director, 10%+ Owner Series A Warrants to Purchase Common Stock 38,916,562 16 Jun 2023 Indirect
MedAvail Holdings, Inc. Director, 10%+ Owner Warrants to Purchase Shares of Common Stock 12,069,628 01 Jul 2022 Indirect
MedAvail Holdings, Inc. Director, 10%+ Owner Warrants to Purchase Shares of Common Stock 9,548,897 01 Jul 2022 Direct
Shattuck Labs, Inc. Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 7,198,553 25 Aug 2025 Indirect
Shattuck Labs, Inc. Director, 10%+ Owner Common Warrants to Purchase Common Stock 4,097,730 25 Aug 2025 Indirect
Augmedix, Inc. Director, 10%+ Owner Breakeven Warrant 1,093,799 20 Nov 2023 Direct
Augmedix, Inc. Director, 10%+ Owner Breakeven Warrant 1,093,799 20 Nov 2023 Indirect
Absci Corp Director Stock Option (Right to Buy) 36,274 12 Jun 2024 Indirect
Shattuck Labs, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 33,150 14 Jul 2025 Indirect
Adagio Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 10 Aug 2021 Indirect
Augmedix, Inc. Director, 10%+ Owner Breakeven Warrants 0 02 Oct 2024 Direct
Augmedix, Inc. Director, 10%+ Owner Breakeven Warrants 0 02 Oct 2024 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 02 Nov 2021 Indirect
IGM Biosciences, Inc. Director, 10%+ Owner Pre-Funded Warrants to Purchase Common Stock 0 14 Aug 2025 Indirect
RayzeBio, Inc. 10%+ Owner Series B Preferred Stock 0 19 Sep 2023 Indirect
RayzeBio, Inc. 10%+ Owner Series C Preferred Stock 0 19 Sep 2023 Indirect
RayzeBio, Inc. 10%+ Owner Series D Preferred Stock 0 19 Sep 2023 Indirect
Science 37 Holdings, Inc. Former 10% Owner and Director Earn-Out Right 0 12 Mar 2024 Indirect
Science 37 Holdings, Inc. Former 10% Owner and Director Stock Options (Right to Buy) 0 12 Mar 2024 Indirect
Verve Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 21 Jun 2021 Indirect

Insider Reports Filed by Redmile Group, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADCT ADC Therapeutics SA 27 Oct 2025 2 +$29,999,993 4 10%+ Owner 28 Oct 2025, 21:00
STTK Shattuck Labs, Inc. 25 Aug 2025 2 $0 4 Director, 10%+ Owner 26 Aug 2025, 17:00
IGMS IGM Biosciences, Inc. 14 Aug 2025 3 $0 4 Director, 10%+ Owner 15 Aug 2025, 17:00
STTK Shattuck Labs, Inc. 14 Jul 2025 1 $0 4 Director, 10%+ Owner 16 Jul 2025, 21:00
IGMS IGM Biosciences, Inc. 30 Jun 2025 1 $0 4 Director, 10%+ Owner 02 Jul 2025, 16:01
ADCT ADC Therapeutics SA 11 Jun 2025 2 +$96,780,687 4 10%+ Owner 13 Jun 2025, 18:00
FATE FATE THERAPEUTICS INC 29 May 2025 1 $0 4 Director, 10%+ Owner 30 May 2025, 18:54
ATRA Atara Biotherapeutics, Inc. 16 May 2025 0 $0 3 Director 23 May 2025, 16:01
IGMS IGM Biosciences, Inc. 31 Mar 2025 1 $0 4 Director, 10%+ Owner 02 Apr 2025, 21:00
IGMS IGM Biosciences, Inc. 31 Dec 2024 1 $0 4 Director, 10%+ Owner 02 Jan 2025, 21:00
FATE FATE THERAPEUTICS INC 20 Dec 2024 7 $0 4 Director, 10%+ Owner 26 Dec 2024, 21:00
FATE FATE THERAPEUTICS INC 12 Dec 2024 2 $0 4 Director, 10%+ Owner 16 Dec 2024, 21:00
ADCT ADC Therapeutics SA 11 Dec 2024 4 +$609,000 4 10%+ Owner 13 Dec 2024, 21:00
ADCT ADC Therapeutics SA 04 Dec 2024 7 +$107,590 4 10%+ Owner 06 Dec 2024, 21:00
STTK Shattuck Labs, Inc. 04 Dec 2024 4 $0 4 Director, 10%+ Owner 06 Dec 2024, 21:00
/report/000110465924106315-redmile-group-llc-2024-10-02 Augmedix, Inc. 02 Oct 2024 7 -$75,402,504 4 Director, 10%+ Owner 04 Oct 2024, 17:01
IGMS IGM Biosciences, Inc. 30 Sep 2024 1 $0 4 Director, 10%+ Owner 02 Oct 2024, 20:16
ADCT ADC Therapeutics SA 01 Jul 2024 2 +$2,248,000 4 10%+ Owner 03 Jul 2024, 20:00
IGMS IGM Biosciences, Inc. 28 Jun 2024 1 $0 4 Director, 10%+ Owner 02 Jul 2024, 21:30
STTK Shattuck Labs, Inc. 21 Jun 2024 1 $0 4 Director, 10%+ Owner 21 Jun 2024, 19:22
/report/000110465924073005-redmile-group-llc-2024-06-14 Augmedix, Inc. 14 Jun 2024 1 $0 4 Director, 10%+ Owner 18 Jun 2024, 21:30
ABSI Absci Corp 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 19:47
FATE FATE THERAPEUTICS INC 07 Jun 2024 1 $0 4 Director, 10%+ Owner 11 Jun 2024, 18:19
ADCT ADC Therapeutics SA 08 May 2024 2 +$68,669,386 4 10%+ Owner 10 May 2024, 16:01
STTK Shattuck Labs, Inc. 28 Mar 2024 1 $0 4 Director, 10%+ Owner 01 Apr 2024, 21:32
IGMS IGM Biosciences, Inc. 28 Mar 2024 2 $0 4 Director, 10%+ Owner 01 Apr 2024, 21:30
FATE FATE THERAPEUTICS INC 21 Mar 2024 1 +$19,996,366 4 Director, 10%+ Owner 25 Mar 2024, 21:30
/report/000110465924036336-redmile-group-llc-2024-03-15 Augmedix, Inc. 15 Mar 2024 1 $0 4 Director, 10%+ Owner 19 Mar 2024, 21:30
IGMS IGM Biosciences, Inc. 12 Mar 2024 1 $0 4 Director, 10%+ Owner 14 Mar 2024, 19:45
/report/000110465924034011-redmile-group-llc-2024-03-12 Science 37 Holdings, Inc. 12 Mar 2024 3 -$5,848,917 4 Former 10% Owner and Director 13 Mar 2024, 17:17
ABSI Absci Corp 01 Mar 2024 1 +$999,999 4 Director 05 Mar 2024, 21:30
IGMS IGM Biosciences, Inc. 28 Feb 2024 2 $0 4 Director, 10%+ Owner 01 Mar 2024, 21:30
ADCT ADC Therapeutics SA 03 Jan 2024 22 -$167,175 4 10%+ Owner 09 Feb 2024, 21:50
ADCT ADC Therapeutics SA 02 Jan 2024 0 $0 3 10%+ Owner 09 Feb 2024, 21:45
IGMS IGM Biosciences, Inc. 29 Dec 2023 1 $0 4 Director 03 Jan 2024, 20:46
FATE FATE THERAPEUTICS INC 26 Dec 2023 3 +$166,024 4 Director, 10%+ Owner 28 Dec 2023, 21:30
STTK Shattuck Labs, Inc. 21 Dec 2023 1 $0 4 Director, 10%+ Owner 26 Dec 2023, 21:30
/report/000110465923127455-redmile-group-llc-2023-12-15 Augmedix, Inc. 15 Dec 2023 1 $0 4 Director, 10%+ Owner 19 Dec 2023, 21:31
/report/000110465923120752-redmile-group-llc-2023-11-20 Augmedix, Inc. 20 Nov 2023 4 +$6,000,000 4 Director, 10%+ Owner 22 Nov 2023, 16:15
IGMS IGM Biosciences, Inc. 29 Sep 2023 1 $0 4 Director 03 Oct 2023, 20:44
/report/000110465923102920-redmile-group-llc-2023-09-19 RayzeBio, Inc. 19 Sep 2023 6 $0 4 10%+ Owner 21 Sep 2023, 22:30
/report/000110465923100910-redmile-group-llc-2023-09-14 RayzeBio, Inc. 14 Sep 2023 0 $0 3 10%+ Owner 14 Sep 2023, 22:31
/report/000110465923098443-redmile-group-llc-2023-08-31 Augmedix, Inc. 31 Aug 2023 1 +$10,000 4 Director, 10%+ Owner 05 Sep 2023, 22:45
/report/000110465923081724-redmile-group-llc-2023-07-13 Augmedix, Inc. 13 Jul 2023 1 $0 4 Director, 10%+ Owner 17 Jul 2023, 18:49
IGMS IGM Biosciences, Inc. 29 Jun 2023 5 $0 4 Director 03 Jul 2023, 21:45
IGMS IGM Biosciences, Inc. 26 Jun 2023 1 +$22,500,000 4 Director 28 Jun 2023, 21:45
/report/000110465923073463-redmile-group-llc-2023-06-16 MedAvail Holdings, Inc. 16 Jun 2023 2 $0 4 Director, 10%+ Owner 21 Jun 2023, 21:45
ABSI Absci Corp 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 19:14
FATE FATE THERAPEUTICS INC 06 Jun 2023 1 $0 4 Director, 10%+ Owner 08 Jun 2023, 19:22
STTK Shattuck Labs, Inc. 26 May 2023 1 $0 4 Director, 10%+ Owner 31 May 2023, 18:40
/report/000110465923061088-redmile-group-llc-2023-05-11 Science 37 Holdings, Inc. 11 May 2023 1 +$125,000 4 Director, 10%+ Owner 15 May 2023, 21:32
/report/000110465923056207-redmile-group-llc-2023-05-02 Augmedix, Inc. 02 May 2023 3 -$15,000,000 4 Director, 10%+ Owner 04 May 2023, 21:30
FATE FATE THERAPEUTICS INC 20 Apr 2023 2 +$1,705,829 4 Director, 10%+ Owner 21 Apr 2023, 21:55
/report/000110465923048544-redmile-group-llc-2023-04-19 Augmedix, Inc. 19 Apr 2023 2 +$6,999,999 4 Director, 10%+ Owner 21 Apr 2023, 21:30
FATE FATE THERAPEUTICS INC 13 Apr 2023 12 -$1,611,460 4 Director, 10%+ Owner 17 Apr 2023, 21:30
IGMS IGM Biosciences, Inc. 04 Apr 2023 1 $0 4 Director, 10%+ Owner 06 Apr 2023, 21:30
IGMS IGM Biosciences, Inc. 31 Mar 2023 1 $0 4 Director, 10%+ Owner 04 Apr 2023, 21:32
/report/000110465923031943-redmile-group-llc-2023-03-09 MedAvail Holdings, Inc. 09 Mar 2023 2 +$24,999,999 4 Director, 10%+ Owner 13 Mar 2023, 21:30
IGMS IGM Biosciences, Inc. 30 Dec 2022 1 $0 4 Director, 10%+ Owner 04 Jan 2023, 20:33
ZYME Zymeworks Inc. 13 Oct 2022 1 +$153,435 4/A 10%+ Owner 18 Oct 2022, 06:07
ZYME Zymeworks Inc. 13 Oct 2022 0 $0 3 10%+ Owner 17 Oct 2022, 21:46
ZYME Zymeworks Inc. 13 Oct 2022 0 $0 3 10%+ Owner 17 Oct 2022, 21:45
IGMS IGM Biosciences, Inc. 03 Oct 2022 6 $0 4 Director, 10%+ Owner 05 Oct 2022, 17:01
IGMS IGM Biosciences, Inc. 30 Sep 2022 1 $0 4 Director, 10%+ Owner 04 Oct 2022, 22:01
/report/000110465922077763-redmile-group-llc-2022-07-01 MedAvail Holdings, Inc. 01 Jul 2022 4 +$18,116,562 4 Director, 10%+ Owner 06 Jul 2022, 17:17
IGMS IGM Biosciences, Inc. 30 Jun 2022 1 $0 4 Director, 10%+ Owner 05 Jul 2022, 21:45
/report/000110465922071543-redmile-group-llc-2022-06-13 Science 37 Holdings, Inc. 13 Jun 2022 2 $0 4 Director, 10%+ Owner 15 Jun 2022, 18:02
FATE FATE THERAPEUTICS INC 09 Jun 2022 2 $0 4 Director, 10%+ Owner 13 Jun 2022, 21:31
STTK Shattuck Labs, Inc. 08 Jun 2022 1 $0 4 Director, 10%+ Owner 10 Jun 2022, 21:32
ABSI Absci Corp 08 Jun 2022 1 $0 4 Director, 10%+ Owner 10 Jun 2022, 21:30
/report/000110465922064848-redmile-group-llc-2022-05-23 Science 37 Holdings, Inc. 23 May 2022 1 +$124,998 4 Director, 10%+ Owner 25 May 2022, 21:30
/report/000110465922043369-redmile-group-llc-2022-04-04 MedAvail Holdings, Inc. 04 Apr 2022 2 +$14,999,999 4 Director, 10%+ Owner 06 Apr 2022, 21:45
IGMS IGM Biosciences, Inc. 31 Mar 2022 2 +$59,999,985 4 Director, 10%+ Owner 04 Apr 2022, 21:45
IGMS IGM Biosciences, Inc. 12 Mar 2022 1 $0 4 Director, 10%+ Owner 15 Mar 2022, 21:45
IGMS IGM Biosciences, Inc. 31 Dec 2021 1 $0 4 Director, 10%+ Owner 04 Jan 2022, 20:45
TRDA Entrada Therapeutics, Inc. 02 Nov 2021 3 +$20,000,000 4 10%+ Owner 04 Nov 2021, 21:00
/report/000110465923048555-redmile-group-llc-2021-10-28-restatement Augmedix, Inc. 28 Oct 2021 1 +$6,500,000 4/A Director, 10%+ Owner 21 Apr 2023, 21:53
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 0 $0 3 10%+ Owner 28 Oct 2021, 21:01
/report/000110465921125511-redmile-group-llc-2021-10-07 Science 37 Holdings, Inc. 07 Oct 2021 1 $0 4 Director, 10%+ Owner 12 Oct 2021, 21:00
/report/000110465921127164-redmile-group-llc-2021-10-06-restatement Science 37 Holdings, Inc. 06 Oct 2021 1 $0 4/A Director, 10%+ Owner 18 Oct 2021, 16:06
/report/000110465921124786-redmile-group-llc-2021-10-06 Science 37 Holdings, Inc. 06 Oct 2021 0 $0 3 Director, 10%+ Owner 08 Oct 2021, 21:01
IGMS IGM Biosciences, Inc. 30 Sep 2021 1 $0 4 Director, 10%+ Owner 04 Oct 2021, 21:01
IVVD Adagio Therapeutics, Inc. 10 Aug 2021 3 +$24,990,000 4 10%+ Owner 12 Aug 2021, 21:01
IVVD Adagio Therapeutics, Inc. 05 Aug 2021 0 $0 3 10%+ Owner 05 Aug 2021, 21:07
ABSI Absci Corp 26 Jul 2021 5 +$5,000,000 4 Director 28 Jul 2021, 21:01
ABSI Absci Corp 21 Jul 2021 0 $0 3 Director, 10%+ Owner 21 Jul 2021, 21:31
IGMS IGM Biosciences, Inc. 30 Jun 2021 1 $0 4 Director, 10%+ Owner 02 Jul 2021, 16:32
VERV Verve Therapeutics, Inc. 21 Jun 2021 3 +$19,950,000 4 10%+ Owner 23 Jun 2021, 16:16
STTK Shattuck Labs, Inc. 19 Jun 2021 1 $0 4 Director, 10%+ Owner 22 Jun 2021, 20:09
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 21:00
FATE FATE THERAPEUTICS INC 02 Jun 2021 2 $0 4 Director, 10%+ Owner 04 Jun 2021, 16:07